Pemetrexed in Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT00424723 · COMPLETED

Trial details

NCT number: NCT00424723
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2005-12-01
Primary completion: 2007-01-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.